Last updated: February 7, 2022
Sponsor: Organon and Co
Overall Status: Completed
Phase
3
Condition
Allergy (Pediatric)
Acute Rhinitis
Common Cold
Treatment
N/AClinical Study ID
NCT00794378
P03829
Ages 6-11 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Subjects must be:
- Between 6 and 11 years of age in good general health
- Premenarcheal if female
Exclusion
Exclusion Criteria: Subjects who:
- Have known allergies or sensitivities to either of the drug formulations
- Have a medical condition that may interfere with the subject's ability to discriminatebetween tastes
- Have used any antihistamines within 24 hours prior to dosing
- Were taking sedatives, tranquilizers, or monoamine oxidase inhibitor drugs
- Were involved in another clinical or market research study within the past 30 days
Study Design
Total Participants: 202
Study Start date:
November 01, 2004
Estimated Completion Date:
November 30, 2004